We are live on
!
Find out more
OCM
Orchard Capital Management Portfolio holdings
AUM
$95.9M
1-Year Est. Return
45.49%
This Fund
S&P 500
This Quarter
Est. Return
+17.22%
1 Year Est. Return
+45.49%
3 Year Est. Return
+102.21%
5 Year Est. Return
+110.9%
10 Year Est. Return
–
AUM
$298M
AUM Growth
+$30.9M
(+12%)
Cap. Flow
+$9.73M
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
42.64%
Holding
56
New
7
Increased
8
Reduced
6
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$15.2M |
| 2 |
OmniAb
OABI
|
+$6.72M |
| 3 |
Standard Motor Products
SMP
|
+$5.99M |
| 4 |
EHAB
Enhabit
EHAB
|
+$4.47M |
| 5 |
DigitalBridge
DBRG
|
+$3.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameris Bancorp
ABCB
|
+$7.15M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$6.5M |
| 3 |
Viasat
VSAT
|
+$5.51M |
| 4 |
The Bancorp
TBBK
|
+$5.51M |
| 5 |
Columbus McKinnon
CMCO
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.3% |
| 2 | Industrials | 20.56% |
| 3 | Healthcare | 13.09% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.35% |
Similar funds
EP
AWA
FFS
SPH
SIM
WAM
SA
FA
Orchard Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Orchard Capital Management held 56 positions worth $298M, up 12% from $267M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Orchard Capital Management deployed $9.73M of net new capital in Q4 2022, opening 7 new positions and adding to 8 existing holdings. Its largest new stake was Wabtec: 158,644 shares worth $5.1M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Ameris Bancorp, an estimated $7.15M trimmed.
- Orchard Capital Management's largest Q4 2022 buy was Wabtec: 158,644 shares worth $5.1M.
- Orchard Capital Management added most to Enhabit in Q4 2022, an estimated $4.47M increase.
- Orchard Capital Management's biggest Q4 2022 reduction was Ameris Bancorp, cutting an estimated $7.15M.
- Orchard Capital Management fully exited Ligand Pharmaceuticals in Q4 2022, selling an estimated $6.5M.
- Orchard Capital Management's ten largest holdings make up 43% of its $298M portfolio in Q4 2022.
- Orchard Capital Management opened 7 new positions and closed 5 in Q4 2022.
- Orchard Capital Management's portfolio value rose 12% quarter-over-quarter to $298M.
Based on Orchard Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.